The rise of passive investing has been one of the great success stories of modern finance. Low costs, broad diversification and reliable market exposure have helped millions of investors build wealth. Yet passive investing carries a risk that is rarely discussed: investors may no longer be buying ‘the market’ but instead placing an ever-larger bet on a handful of companies.
The reason for this is simple. Major benchmark indices are no longer the broad representation of corporate health that many assume them to be.
The numbers are striking. In the S&P 500, the largest 10 companies account for around 40 per cent of the index's market value, a concentration well above levels that have prevailed for much of the past three decades. The Magnificent Seven alone represent roughly a third of the index. A similar trend is visible in the UK, where a relatively small group of large-cap stocks account for a disproportionate share of the FTSE All-Share's value and recent performance.
This creates a dilemma for active managers. A genuinely diversified portfolio is increasingly likely to look very different from the benchmark. That can of course lead to periods of underperformance when mega-cap stocks continue their relentless ascent. It can however also reduce the risk of painful losses should sentiment towards those market leaders reverse.
History suggests market leadership is rarely permanent. The companies that dominate one decade do not always lead the next. In a world where stock market indices are becoming ever more concentrated, diverging from the benchmark should not automatically be viewed as a weakness. It may instead simply reflect prudent diversification, sensible risk management, and a willingness to seek opportunities beyond today's narrow group of market winners.
Capital at risk.
